Entering text into the input field will update the search result below

CrowdStrike Is Priced Like A Superstar

Jul. 25, 2019 12:42 PM ETCrowdStrike Holdings, Inc. (CRWD)7 Comments

Summary

  • CrowdStrike annual revenue growth is over 100%.
  • The share price has gone up 2.5x in 1 1/2 months since IPO and my relative valuation analysis suggests that the share price is overvalued.
  • Gartner's peer reviews suggests that CrowdStrike is preferred over Cylance and Carbon Black for endpoint security solutions.
  • I expect that there will be a dip in share price or pause in share price growth in the next 6-12 months due to insider lockup expiration.
  • At present, I give CrowdStrike a neutral rating due to overvaluation and insider lockup.

CrowdStrike Holdings, Inc. (NASDAQ:CRWD) is the talk of the town, as the share price has gone up 2.5x since its IPO, from $34 to $86.50 in 1 1/2 months. CrowdStrike appears to have hit the sweet spot of the endpoint security market. I believe that CrowdStrike has a superior product and that is reflected in strong revenue growth. But the lofty valuation is an issue and because it is an IPO, investors need to be concerned about insider lockup expiration. I feel it is prudent to wait at least 6-12 months then look for a better entry price before buying this stock. For now, I have to give the stock a neutral rating.

CrowdStrike statistics from the prospectus

(Source: CrowdStrike prospectus)

Competition

CrowdStrike’s competition falls into 3 categories: legacy antivirus product providers, alternative endpoint security providers, and network security providers.

Legacy antivirus product providers such as McAfee and Symantec (SYMC) are the old guard and are quickly being replaced by modern solutions built from the ground up. Legacy vendors require constant software updates and can’t respond to threats with the speed of a real-time, crowd-sourced, end-point solution enhanced by AI.

Alternative endpoint security providers such as Carbon Black (CBLK) and Cylance which is owned by BlackBerry (BB) are the prime competitors for CrowdStrike, but they are proving to be no match. Both Carbon Black and Cylance have YoY revenue growth of approximately 30%. Meanwhile, CrowdStrike is growing at a rate of more than 100% per year with a very sticky product.

The dollar-based gross retention rate is a phenomenal 98% and dollar-based net retention is 147% due to a large number of apps in the suite. Cylance is CrowdStrike’s biggest threat, but it is unlikely to undertake a “win-at-all-costs” strategy that SaaS companies generally employ to gain market share. Such a capital-intense strategy would be difficult for BlackBerry's management at this point

This article was written by

Steve Auger profile picture
6.6K Followers
Invest in high growth software stocks now

I have been trading stocks, commodities, and options for more than 25 years. I have honed my skills in quantitative analysis and various stock investment tools for 15 years at Portfolio123 and offer services as a consultant in stock portfolios. I also own the financial data service Equity Analytx which provides aggregated fundamentals for a wide range of industries.

Analyst’s Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.